CBS 2019
CBSMD教育中心
中 文

急性冠脉综合征

Abstract

Recommended Article

Aggressive Measures to Decrease Causes of delay and associated mortality in patients transferred with ST-segment-elevation myocardial infarction High-Sensitivity Troponins and Outcomes After Myocardial Infarction Cardiovascular Mortality After Type 1 and Type 2 Myocardial Infarction in Young Adults Improved Outcomes Associated with the use of Shock Protocols: Updates from the National Cardiogenic Shock Initiative Management of Acute Myocardial Infarction During the COVID-19 Pandemic Canadian SCAD Cohort Study: Shedding Light on SCAD From a United Front China PEACE risk estimation tool for in-hospital death from acute myocardial infarction: an early risk classification tree for decisions about fibrinolytic therapy

Original Research2019 Jul;12(7):e005103.

JOURNAL:Circ Cardiovasc Qual Outcomes. Article Link

Comparative Effectiveness of β-Blocker Use Beyond 3 Years After Myocardial Infarction and Long-Term Outcomes Among Elderly Patients

Shavadia JS, Holmes DN, Thomas L et al. Keywords: 3-year post-MI survivors; β-blocker; elderly; observational study; long-term cardiovascular outcomes

FULL TEXT PDF